Therapeutic vulnerability to PARP1,2 inhibition in RB1-mutant osteosarcoma

Loss-of-function mutations in the RB1 tumour suppressor are key drivers in cancer, including osteosarcoma. RB1 loss-of-function compromises genome-maintenance and hence could yield vulnerability to therapeutics targeting such processes. Here we demonstrate selective hypersensitivity to clinically-ap...

Descripción completa

Detalles Bibliográficos
Autores principales: Zoumpoulidou, Georgia, Alvarez-Mendoza, Carlos, Mancusi, Caterina, Ahmed, Ritika-Mahmuda, Denman, Milly, Steele, Christopher D., Tarabichi, Maxime, Roy, Errin, Davies, Lauren R., Manji, Jiten, Cristalli, Camilla, Scotlandi, Katia, Pillay, Nischalan, Strauss, Sandra J., Mittnacht, Sibylle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8642453/
https://www.ncbi.nlm.nih.gov/pubmed/34862364
http://dx.doi.org/10.1038/s41467-021-27291-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8642453/
https://www.ncbi.nlm.nih.gov/pubmed/34862364
http://dx.doi.org/10.1038/s41467-021-27291-8

Ejemplares similares